Avai Bio (AVAI) Current Deferred Tax Assets (2018 - 2020)

Avai Bio (AVAI) has 3 years of Current Deferred Tax Assets data on file, last reported at -$14078.0 in Q1 2020.

• For the quarter ending Q1 2020, Current Deferred Tax Assets rose 15.1% year-over-year to -$14078.0; the trailing twelve-month figure through Mar 2020 stood at -$14078.0 (up 15.1% YoY), and the FY2020 full-year result was -$14078.0, up 15.1% from the prior year.
• Current Deferred Tax Assets advanced to -$14078.0 in Q1 2020, from -$16582.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of -$155.0 in Q1 2018 to a low of -$16582.0 in Q1 2019.
• A 3-year average of -$8029.2 and a median of -$7689.8 in 2020 frame the typical range for Current Deferred Tax Assets.
• Across the five-year window, Current Deferred Tax Assets slumped 10598.06% in 2019 and increased 15.1% in 2020, its largest moves.
• Tracing AVAI's Current Deferred Tax Assets over 3 years: stood at -$1301.6 in 2018, then sank by 1173.96% to -$16582.0 in 2019, then rose by 15.1% to -$14078.0 in 2020.
• Business Quant data shows AVAI's Current Deferred Tax Assets at -$14078.0 in Q1 2020, -$16582.0 in Q1 2019, and -$1301.6 in Q2 2018.